Soochow Chirally Material Science andTechnology Co.,Ltd ("Chirally") successfully participated in the 23rdCPHI China 2025 and 18th PMEC China 2025, held at the Shanghai NewInternational Expo Centre in June 24-26th. Partnering with Shanghai PHEXCO,Chirally leveraged a shared exhibition platform to deeply engage in thispremier global event covering the entire pharmaceutical supply chain.

The year's record-breaking event spanned 230,000 square meters and attracted over 3,500 domestic and international exhibitors, including industry leaders such as Merck, Catalent, Sinopharm Group, and Fosun Pharma. Drawing more than 100,000 professional visitors from over 140 countries and regions, the exhibition saw a significant 16% year-on-year increase in overseas attendees, with 74% holding purchasing decision-making authority. It served as an exceptional platform for Chinese enterprises to connect with the global market and showcase technological innovation.

The collaborative exhibition strategy withShanghai PHEXCO efficiently combined resources and created synergistic brandvisibility. Chirally's booth was consistently busy, attracting numerousinternational and domestic buyers for in-depth discussions. Through preciselytargeted procurement matchmaking meetings, Chirally effectively connected itsproduct technologies with market demands, significantly expanding potentialpartnership channels.

Participation in CPHI China 2025 not only elevated Chirally's brand profile within the pharmaceutical advanced materials sector but also accelerated its internationalization strategy by leveraging Shanghai PHEXCO's established channel resources. Looking ahead, Chirally remains committed to deepening technological innovation, empowering pharmaceutical industry advancement with high-performance material solutions, and collaborating with partners to explore vast new market opportunities globally.